A modified version of an FDA-approved close-loop insulin delivery system may be effective for children aged 2 to 5 years with type 1 diabetes, according to study data published in Diabetes Technology & Therapeutics.
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Aurora, CO 80045